Mineralys Therapeutics, Inc. (MLYS) Balance Sheet
As of 2026-06-30 (10-Q), Mineralys Therapeutics, Inc. (MLYS) reported total assets of $667.9M, total liabilities of $116.9M and shareholders' equity of $550.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $138.3M. Long-term debt: $100000.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MLYSMineralys Therapeutics, Inc.Follow MLYS — free
—
Price chart with a free account
- Market cap
- 1.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash and equivalents | 49.3 | 114.1 | 172.9 | 138.3 | |
| Short-term investments | 187.3 | 84.1 | 483.7 | 523.1 | |
| Current assets | 249.1 | 205.4 | 661.4 | 665.8 | |
| Total assets | 251.6 | 205.9 | 661.8 | 667.9 | |
| Current liabilities | 10.5 | 14.6 | 15.1 | 19.3 | |
| Long-term debt | — | — | — | 0.1 | |
| Total liabilities | — | — | 15.1 | 116.9 | |
| Shareholders' equity | 241.2 | 191.3 | 646.7 | 550.9 |
USD millions · SEC XBRL
Mineralys Therapeutics, Inc. — questions
- How much cash does Mineralys Therapeutics, Inc. have?
- $138.3M in cash and cash equivalents as of 2026-06-30.
- How much debt does Mineralys Therapeutics, Inc. have?
- $100000 of long-term debt as of 2026-06-30.
- What are Mineralys Therapeutics, Inc.'s total assets?
- $667.9M as of 2026-06-30.
- What is Mineralys Therapeutics, Inc.'s shareholders' equity?
- $550.9M as of 2026-06-30.
Every figure on this page comes from Mineralys Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.